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High glucoseCardiac fibroblasts significantly contribute to diabetes-induced structural and functional changes in the myocar-
dium. The objective of the present study was to determine the effects of high glucose (alone or supplemented
with angiotensin II) in the activation of the JAK2/STAT3 pathway and its involvement in collagen I production
by cardiac fibroblasts. We observed that the diabetic environment 1) enhanced tyrosine phosphorylation of
JAK2 and STAT3; 2) induced nuclear localization of tyrosine phosphorylated STAT3 through a reactive oxygen
species-mediated mechanism, with angiotensin II stimulation further enhancing STAT3 nuclear accumulation;
and 3) stimulated collagen I production. The effects were inhibited by depletion of reactive oxygen species or
silencing of STAT3 in high glucose alone or supplemented with exogenous angiotensin II. Combined, our data
demonstrate that increased collagen I deposition in the setting of high glucose occurred through a reactive
oxygen species- and STAT3-dependent mechanism. Our results reveal a novel role for STAT3 as a key signaling
molecule of collagen I production in cardiac fibroblasts exposed to a diabetic environment.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Extracellularmatrix is an important component ofmyocardial archi-
tecture and regulator of function of the left ventricle (LV), and is dynam-
ically regulated by cardiac fibroblasts [1]. Fibroblast proliferation and a
dysregulated balance between enhanced extracellular matrix synthesis
and degradation can evolve into a state offibrosiswith important effects
on function by increasing LV stiffness. A prominent component of
diabetic cardiomyopathy is cardiac fibrosis, a pathological condition
characterized by alterations in the structure and function of the heart
that includes increases in deposition of extracellular matrix proteins
(e.g., collagen I) in the absence of coronary artery disease [2–4].
The activation of fibrogenic pathways can be evoked by stimuli inde-
pendent of cardiomyocyte loss. High glucose (25 mM) was found to
promote fibrosis in vitro by increasing cardiac fibroblast protein andLV, left ventricle; MMP, matrix
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and up-regulating mRNA expression of angiotensin II (Ang II) AT1
receptor [5]. Ang II plays a critical role in LV remodeling by promoting
cardiomyocyte hypertrophy and cardiac fibroblast proliferation, synthe-
sis, and secretion of adhesion molecules and extracellular matrix
proteins [6].
High glucose also importantly affects Ang II receptor signaling. In
non-failing cardiomyocytes incubated in a diabetic environment, Ang
II induces reactive oxygen species (ROS)-dependent JAK2 tyrosine
phosphorylation [7] followed by signal transducer and activator of tran-
scription 3 (STAT3) tyrosine phosphorylation and B cell lymphoma
(Bcl)-xL overexpression. The transcriptional activity of STAT3 is coordi-
nated by ERK1/2 activation [8]. STAT3 belongs to the family of STAT pro-
teins, activated in response to extracellular signaling proteins [9,10].
The phosphorylation of STAT3 at tyrosine 705 permits dimerization
followed by transport of the dimer into the nucleus [11], where the
dimer binds to a consensus DNA sequence in the promoters of its target
genes to regulate transcription [12]. STAT3 participates in the transcrip-
tion of target genes in ischemia/reperfusion injury [13,14], pressure-
overload hypertrophy [15], cardio-protection [16], and angiogenesis
[17]. Recently, the protective role of STAT3 was challenged by evidence
showing that IL-6 mediated STAT3 activation may also induce intersti-
tial fibrosis [18]. In addition, the STAT3 cardio-protective response was
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tions in the physiology of the heart (protective and pro-fibrotic), the
molecular mechanism responsible for fibrosis involving STAT3 has not
been fully elucidated in cardiac fibroblasts.
Based on this background, the current manuscript evaluated the ef-
fect of exposing cardiac fibroblasts to a high glucose alone or supple-
mented with Ang II. Our findings revealed novel roles for STAT3 to
enhance collagen I synthesis in the setting of high glucose.2. Materials and methods
2.1. Materials
Unless specified, all reagents were obtained from Sigma. Anti-actin
(sc-1615), anti-JAK2 (sc-278), anti-p-JAK2-Tyr 1007 (sc-101717), anti-
MMP-2 (sc-10736) antibodies, STAT3 siRNA (sc-270027) and scramble
siRNA were from Santa Cruz Biotechnology. Antibody anti p-STAT3-Tyr
705 (catalog number 91315) was from Cell Signaling. Antibodies anti-
collagen I (ab34710) was from Abcam. TransIT-TKO Transfection
Reagent was from Mirus (Catalog number MIR2154). 488Alexa Fluor-
conjugated secondary antibodies and 2′,7′-dichlorfluorescein-diacetate
(DCF-DA) were fromMolecular Probe (catalog number D-399). Amicon
Ultra centrifugal filters (10 K)were fromMillipore. Bradford solution for
protein assay detection was from Biorad (catalog number 500–0006).2.2. Cardiac fibroblast isolation, culture, and stimulation with Ang II
Cardiac fibroblasts were isolated from the LV of 5-day-old
Sprague–Dawley rats. In brief, LVs were harvested, cut into small
pieces (~1–2 mm), placed in a Petri dish and covered with a glass
slide. A total of 10mLof Dulbecco'smodified Eagle'smediumcontaining
10% fetal bovine serum and penicillin (100 U/mL) was added to Petri
dishes. Petri dishes are maintained at 37 °C under 5% CO2 in a
humidified incubator to permit outgrowth of the fibroblasts from the
tissue. Only cells that adhered to the plate grew and were passaged.
The purity of the fibroblast population was about 99%, as assayed
by vimentin, cytokeratin, and α-smooth muscle actin expression
(Suppl. Fig. 1). Cells from passages 2 or 3 were used for all experiments.
Cells were maintained in DMEM containing 5.5 mM (normal glucose,
NG) or 25 mM glucose (high glucose, HG) corresponding to plasma
levels of 100 and 450 mg/dL, respectively. Differences in osmolarity
between normal glucose and high glucose media were corrected by
adding 19.5 mM of mannitol to the normal glucose medium.
Fibroblasts were treated with serum-free normal glucose medium
overnight. For high glucose samples stimulatedwith Ang II, high glucose
mediumwas added to fibroblasts 2 h before Ang II addition. In all exper-
iments, high glucose is maintained for the entire time and never re-
moved. For Ang II stimulation, cells were serum deprived overnight
before stimulation with Ang II (100 nM final). The generic ROS scaven-
ger N-acetyl-cysteine (NAC) (20 mM final) was added to the medium
15 min before Ang II stimulation and maintained throughout the
experiment.2.3. STAT3 silencing
Specific silencing of STAT3 was performed by fibroblast transfection
with small-interfering-RNA (siRNA) using TransIT Transfection Reagent
according to manufacturer's instruction. Briefly, 48 h after silencing, fi-
broblasts were serum-deprived for 24 h in normal glucose medium
and treated with high glucose or normal glucose for additional 24 h
(both culture media with or without Ang II, 100 nM final). Not-
targeting siRNA (scramble) was used as a negative control. Viability of
STAT3-silenced cells was evaluated by MTT assay.2.4. Immunoblot analysis
Cardiacfibroblastswere lysed for 20min on ice in 500 μL of complete
radio-immunoprecipitation assay (RIPA) buffer. Lysates were clarified
by centrifugation, and total protein contents were obtained using a
Bradford assay. A total of 20 μg of total protein for each sample were
separated by SDS-PAGE and transferred onto PVDF membranes. PVDF
membraneswere incubated in 2%milk, probedwithprimary antibodies,
and incubated with secondary antibodies conjugated with Horseradish
Peroxidase. Band intensity was measured by ImageJ. Actin and total
STAT3 or JAK2 was used for normalization.
2.5. ROS evaluation
ROS generation in cardiac fibroblasts was measured using 2′,7′-
dichlorfluorescein-diacetate (DCF-DA), a fluorogenic dye that binds to
ROS. Within the cell, DCFDA is deacetylated by cellular esterase to a
non-fluorescent compound, which is later oxidized by cellular ROS
into the highly fluorescent compound 2′, 7′—dichlorofluorescin (DCF).
A total of 5 μM DCF-DA was added to sub-confluent cells for 3 min.
Cells were lysed in 1 mL RIPA buffer containing 1% Triton X-100 and
fluorescence was immediately analyzed using a fluorescence spectro-
photometer (excitation wavelength: 488 nm, emission wavelength:
510 nm). The fluorescence values were normalized for total protein
content.
2.6. Nuclear localization of phosphorylated Tyr 705 STAT3 by confocal
analysis
Cardiac fibroblasts were seeded onto coverslips, stimulated with
Ang II (100 nM) for 1 h, washed with phosphate buffered saline, and
fixed in 3% paraformaldehyde for 20 min at 4 °C. Fixed cells were
permeabilized with three washes with 0.1% Triton X-100 (in 50 mM
Tris–HCl, pH 7.4, 150 mM NaCl) (TBST) and blocked with 5.5% horse
serum in TBST for 1 h at room temperature. Cells were incubated with
p-Tyr 705 STAT3 primary antibodies overnight at 4 °C. Cells were
incubated with 488 Alexa Fluor-conjugated secondary antibodies
(diluted 1:100) for 1 h at room temperature in TBST containing 3% bo-
vine serum albumin. Nuclei were identified by labeling the cells with
propidium iodide (50 mg/L) for 10 min at room temperature. After ex-
tensive washes in TBST, cells were mounted with glycerol plastine and
observed under a laser scanning confocal microscope (Leica TCS SP5).
2.7. Zymography
Zymography was performed on collected culture media. A total of
3 × 105 fibroblasts were cultured in 1.5 mL of medium. Conditioned
media (20 μL) was subjected to electrophoresis on 8% SDS-PAGE co-
polymerized with 0.1% (w/v) type A gelatin. Equal loading was ensured
by measuring total protein content for each sample. Gels were washed
twice in 2.5% v/v Triton X-100 for 30 min and incubated in 50 mM
Tris–HCl, pH 7.4, 200 mM NaCl and 5 mM CaCl2 at 37 °C for 24 h.
After incubation, the gels were stained with 0.1% Coomassie brilliant
blue in acetic acid, methanol, and distilled water (1:2:3) for 1 h at
room temperature. After destaining, the gels were immersed in distilled
water. Bands of gelatinase activity appeared as transparent area against
a blue background. The intensity of the bands was measured using
ImageJ. Conditioned medium of the fibrosarcoma cell line HT1080 is
used as positive control of MMP-2.
2.8. Analysis of collagen I deposition
Fibroblasts (3 × 105 cells) were cultured in 1.5mL of culture medium.
Conditioned medium had the same total protein content in each sample
as revealed by protein assay (using Bradford method) and by anti-actin
immunoblot. Conditioned medium (1 mL) was concentrated to 100 μL
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each of the concentrated medium was subjected to immunoblot analysis
for collagen I. The intensities of the bands were analyzed by ImageJ.2.9. Statistical analysis
Data are presented as mean ± S.D. from at least three independent
experiments. Analysis of densitometry was performed using ImageJ.
Statistical analysis of the data was performed by Student's t-test or by
one-way ANOVA using Graph Pad Prism 4.0. p-Values b0.05 were con-
sidered statistically significant.3. Results
3.1. Effects of glucose on JAK2 and STAT3 tyrosine phosphorylation in
cardiac fibroblasts
Phosphorylation on Tyr-1007 of JAK2 (Fig. 1A) and Tyr-705 of STAT3
(Fig. 1B) was 2-fold and 5-fold enhanced under high glucose, compared
to normal glucose. This response in high glucosewas independent of re-
duction in either salt content or osmolarity.Fig. 2. Effect of glucose and Ang II stimulation on ROS production in cardiac fibroblasts.
A) Time-course of ROS production in cardiac fibroblasts under normal and high
glucose levels. B) ROS generation following Ang II stimulation in normal glucose and
after two-hour incubation in high glucose. ROS values were normalized on total protein
content and reported in the bar graph as fold increase vs time 0, with time 0 equal to 1.
*p b 0.01 and #p b 0.01 vs corresponding time in normal glucose. §p b 0.01 vs time 0 in
normal glucose. Data are representative of three independent experiments.3.2. Effects of glucose and Ang II stimulation in ROS generation
To verify the influence of hyperglycemic environment on ROS pro-
duction, we performed a time-course experiment of ROS generation
under high glucose conditions. High glucose provoked a transient
burst of ROS, peaking 15 min after high glucose addition (about 2 fold
enhancement vs time zero). Conversely, fibroblasts in normal glucose
produced ROS levels that did not change for any of the times examined
(Fig. 2A).
Further, we compared ROS production in fibroblasts stimulatedwith
Ang II under normal and high glucose conditions. Ang II stimulation in
normal glucose induced a transient burst of ROS, with peak of produc-
tion 15min after stimulation (Fig. 2B). Ang II stimulation in high glucose
induced a similar timing of effect, with ROS production also peaking
15 min after stimulation, but at higher levels than observed in normal
glucose (Fig. 2B).Fig. 1.Analysis of JAK2 and STAT3 tyrosine phosphorylation in normal and high glucose conditio
Cells were treatedwith high glucose for two h. A) Basal phosphorylation level of Tyr 1007 JAK2 p
phorylation level of Tyr 705 STAT3 innormal and highglucose conditions, by immunoblotting. B
ratio between the phosphorylated and total amount of protein and reported as arbitrary units
representative of three independent analyses with similar results.3.3. Effect of Ang II stimulation in normal or high glucose medium on
tyrosine phosphorylation of JAK2 and STAT3
Ang II stimulation of cardiac fibroblasts in normal glucose induced
1.3-fold increased JAK2 phosphorylation (Fig. 3A) and N10-fold in-
creased STAT3 tyrosine phosphorylation (Fig. 3B), with peak activation
occurring 15–30 min after stimulation. Ang II stimulation of cardiacns. Cardiac fibroblasts were cultured inmedia containing normal glucose (5mM) for 24 h.
hosphorylation in normal and high glucose conditions, by immunoblotting. B) Basal phos-
ar graph inA) and B) shows thephosphorylation level of JAK2and STAT3 obtained from the
(a.u.). #p b 0.01 vs normal glucose; *p b 0.001 vs normal glucose. The immunoblots are
Fig. 3. JAK2 and STAT3 tyrosine phosphorylation byAng II stimulation in normal and high glucose environments. Fibroblasts were serum-deprived for 24 h in normal glucose. High glucose
treatmentwas performed for 2 h. Cells were then stimulatedwith Ang II (100 nM) for the indicated period. A) Representative immunoblot shows the phosphorylation of Tyr 1007 of JAK2
using phospho-specific antibodies. B) Representative immunoblot performed using anti-phospho-Tyr 705 STAT3 antibodies. Bar graph indicates the ratio between the phosphorylated and
the total amount of protein reported as arbitrary unit (a.u.). ç p b 0,01 vs time 0 in normal glucose. *p b 0.01 and #p b 0.001 vs corresponding time in normal glucose. §p b 0,01 vs time 0 in
normal glucose. The immunoblots are representative of three different and independent experiments.
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tion, even after 2 h of stimulation (Fig. 3B). The addition of hydrogen
peroxide to fibroblasts in normal glucose stimulated tyrosine phosphor-
ylation of both JAK2 and STAT3, indicating the involvement of ROS in
JAK2 and STAT3 activation (Suppl. Fig. 2).Fig. 4.Nuclear localization of phosphorylated-Tyr 705 of STAT3 in normal and high glucose con
then treatedwith high glucose for 2 h. Ang II (100 nM) stimulationwas carried out for 1 h. B) Th
performed by treating the fibroblasts as described in A). Before Ang II stimulation the ME
phosphorylated-Tyr 705 STAT3 was carried out by labeling the cells with anti-phospho-Tyr
(green staining). Nuclei were detected by labeling the cells with propidium iodide (red stainin
adding high glucose medium. Fluorescence intensity of the nuclei was analyzed by ImageJ choo
rescence intensity calculated on the number of cells examined (100 cells/experiment) and repor
statistical differences between groups. *p b 0.001 vs corresponding sample without NAC; **p b
corresponding sample without PD98059. The images are representative of four independent e3.4. Nuclear accumulation of pTyr-705 STAT3
Nuclear translocation initiated by Tyr705 phosphorylation is
central to STAT3 transcription factor function [11]. Ang II stimulation
of cardiac fibroblasts under normal glucose condition significantlyditions. A) Cells were seeded on coverslips, serum-deprived for 24 h in normal glucose and
e analysis of ERK1/2 involvement in the nuclear localization of phospho-Tyr 705 STAT3was
K1 inhibitor PD98059 (10 μM final) was added to fibroblasts. Nuclear localization of
705 STAT3 antibodies and then with Alexa Fluor 488-coniugated secondary antibodies
g). For the experiment with NAC, cells were pre-treated with NAC (20 mM) for 1 h before
sing at least six random fields in each experiment. The bar graph shows the mean of fluo-
ted as arbitrary unit (a.u.). One-wayANOVA followed by Tukey's post-testwas used to find
0.01 vs corresponding sample without Ang II; ***p b 0,01 vs normal glucose. §p b 0.01 vs
xperiments.
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crease in the nuclear accumulation of STAT3was also observed in fibro-
blasts after 2 h incubation in high glucose conditions (Fig. 4A).
Furthermore, Ang II stimulation in a high glucose environment caused
a marked increase in the nuclear accumulation of phosphorylated
STAT3 (about a 40% increase compared to high glucose). Pre-
incubation with N-acetyl-cysteine (NAC), before shifting cells to high
glucose, abolished nuclear accumulation of phosphorylated STAT3
(Fig. 4A), demonstrating that nuclear localization of Tyr-705 phosphor-
ylated STAT3 occurred through a ROS-dependent mechanism.
To study the involvement of the ERK1/2 signalingpathway in the en-
hancement of nuclear STAT3 localization observed following Ang II
stimulation in high glucose, fibroblasts were treated with the MEK in-
hibitor PD98059 that specifically inhibits MEK-1-mediated activation
of the ERK1/2 pathway. Pre-treatment of fibroblasts with PD98059 pro-
voked a significant decrease in nuclear STAT3 accumulation (Fig. 4B),
indicating the participation of ERK1/2 in the enhancement of nuclear
STAT3 localization due to Ang II stimulation under high glucose
conditions.
3.5. Collagen I and MMP-2 secretion in conditioned media of cardiac
fibroblasts after 24 h of incubation in normal or high glucose medium
Collagen I is a major component of the LV extracellular matrix, and
dysregulation of collagen I synthesis leads to cardiac fibrosis. A diabetic
environment with high glucose increased collagen I deposition aboutFig. 5.Analysis of collagen I andMMP-2 in normal and high glucose conditionedmedia. Cardiac
was added for an additional 24h.Where indicated, cellswere stimulated for Ang II (100 nM) for
analysis using specific antibodies. The intensity of the bandswas analyzed by ImageJ, and theme
Tukey’s post-test was used to evaluate statistical differences between groups. *p b 0.01. B) Repr
pro-MMP-2 (MW: 72 KDa) and the active MMP-2 (MW: 63 KDa). Bar graph represents themea
blast conditioned media by zymography. Conditioned medium of the fibrosarcoma cell line HT
experiments with similar results.two-fold in comparison to normal glucose conditions (Fig. 5A). In addi-
tion, treatment offibroblastswith Ang II synergizedwithhigh glucose to
further enhance collagen I deposition (1.5-fold vs Ang II in high glucose;
Fig. 5A).
Extracellular matrix deposition is strictly regulated by the balance
between synthesis and degradation processes. Degradation is regulated
by the zinc-dependent matrix metalloproteinases (MMPs), particularly
MMP-2 [19,20]. Cardiac fibroblast MMP-2 expression levels (both
intracellular and extracellular) were not difference under high either
glucose or Ang II stimulation (Fig. 5B and C).3.6. Increased collagen I deposition in high glucose occurs through a ROS- and
STAT3-dependent mechanism
The depletion of ROS by NAC inhibited the increase in collagen I syn-
thesis under high glucose (Fig. 6A). Likewise, ROS participated by addi-
tionally increasing collagen I deposition observed in high glucose and
Ang II treatment, since the addition of NAC decreased collagen I forma-
tion (Fig. 6B). To assess the involvement of STAT3 in collagen I forma-
tion, we silenced STAT3 in cardiac fibroblasts. Viability was unaffected
by STAT3 silencing (Suppl. Fig. 3). Conversely, STAT3 silencing provoked
a decrease of collagen I deposition both under normal and high glucose
conditions (Fig. 6C and Suppl. Fig. 4A). In addition, STAT3 silencing
greatly decreased the enhancement of collagen I formation due to Ang
II stimulation (Fig. 6D and Suppl. Fig. 4B), thus demonstrating STAT3fibroblasts were serum-deprived in normal glucose for 24 h and then high glucosemedium
24h. A)Analysis of collagen I deposition. Collagen I depositionwas assayed by immunoblot
an value is reported in the bar graph as arbitrary units (a.u.). One-wayANOVA followed by
esentative immunoblot of MMP-2 expression in cardiac fibroblasts. Immunoblot shows the
n value reported as arbitrary unit (a.u.). C) MMP-2 secretion was assayed in cardiac fibro-
1080 is used as positive control of MMP-2. Data are representative of three independent
Fig. 6. Increase of collagen I deposition ismediated by a ROS- and STAT3-dependentmechanism. A)Collagen I formation in the setting of high glucose is ROS-dependent. Cardiacfibroblasts
were serum-deprived in normal glucose for 24 h and then in high glucose for an additional 24 h. Where indicated, NAC (20 mM)was added to the media and left throughout the exper-
iment. Collagen I depositionwas assayed as reported inMaterials andmethods section. B) Involvement of ROS in collagen I deposition after Ang II stimulation for 24h. Collagen I is reported
as fold increase vs high glucose or vs high glucose+NAC. C) andD) Collagen I deposition occurs through a STAT3-dependentmechanism. 48 h after silencing STAT3 infibroblasts, the cells
were serum-deprived for 24 h in normal glucose and then treated with normal or high glucose for an additional 24 h. Where indicated, Ang II (100 nM) was added to the culture media.
Silencing of STAT3was detected by immunoblot using an anti-STAT3 antibody (Suppl. Fig. 4) while collagen I releasewas detected as described inMaterial andmethods section. *p b 0.01
vs high glucose; §p b 0.001 vs high glucose+Ang II; #p b 0.05 vs high glucose+ scrambled Ang II; ç p b 0.01 vs normal glucose; $ p b 0.001 vs high glucose. Bar graph reports themean of
three independent analysis, while the immunoblots are representative images of three independent experiments.
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hyperglycemic conditions.
4. Discussion
This paper examined the role of high glucose (alone or in combina-
tionwith Ang II) on the activation of the JAK2/STAT3 signaling pathway
in cardiac fibroblasts. Further, we analyzed STAT3 involvement in colla-
gen I formation in cardiac fibroblasts in hyperglycemic conditions. The
most significant findings were: i) 2 h of pre-incubation of cardiac fibro-
blasts in high glucose induced JAK2 and STAT3 tyrosine phosphoryla-
tion; ii) high glucose increased STAT3 nuclear localization that was
further enhanced by Ang II stimulation; iii) high glucose enhanced col-
lagen I production that was further increased by Ang II treatment; and
iv) increased collagen I, observed in high glucose and high glucose sup-
plemented with Ang II, occurred through ROS- and STAT3-dependent
mechanisms.
Hyperglycemia participates in the onset andworsening of cardiovas-
cular disease. In particular, hyperglycemia may sustain the progression
of heart failure through excessive interstitial myocardial collagen accu-
mulation, thus leading to impaired diastolic and systolic function [21].
Cardiac fibroblasts, one of themajor cell types contributing to structural
and functional properties of the heart [1], are greatly affected by glucose
levels. Indeed, a direct association between heart failure and dysregula-
tion of cardiac fibroblast proliferation and extracellular matrix deposi-
tion has been reported [22–24]. Here we show that hyperglycemia
alone induces the tyrosine phosphorylation of the JAK2/STAT3 signalingpathway. The link between JAK2 and STAT3 in CFs has been previously
reported [25]. Although an increased JAK2 and STAT3 tyrosine
phosphorylation due to high glucose has been previously shown in
mesangial cells [26], this is the first evidence in CFs. We observed a re-
markable increase of STAT3 tyrosine phosphorylation in comparison
to JAK2 in hyperglycemic condition, indicating that high glucose
leads to STAT3 tyrosine phosphorylation by a JAK2-independent
fashion. The tyrosine kinase Src may be a good candidate for JAK2-
independent STAT3 tyrosine phosphorylation. Indeed, Src undergoes
to redox activation following different kind of stimuli leading to ROS
production. In turn, oxidized-activated Src promotes the phosphoryla-
tion/activation of downstream targets, culminating in specific cellular
responses [27]. STAT3 is one of the several downstream substrates of
Src and the involvement of the Src-STAT3 signaling pathway in the car-
dio protection has been recently reported [28]. Furthermore, another
JAK2-independent STAT3 activation mechanism, involving the small
GTPase Rac1, has been reported in atrial myocytes and fibroblasts [29].
Hyperglycemia induces the increase of ROS production provoking apo-
ptosis in cardiomyocytes [30]. As consequence, oxidative stress leads
to the reduction of myocardial contractility and the increased of
myocyte fibrosis [31]. In agreement with the previous findings [32],
we show an increased ROS production in high glucose. Addition of
Ang II, after 2 h of pre-incubation of cells in high glucose, further en-
hanced ROS production. Ang II participates in inducing cardiac myocyte
hypertrophy, fibroblast proliferation and collagen deposition [33–36].
Both cardiac myocytes and fibroblasts produce Ang II leading to an
autocrine/paracrine mechanism [37–39]. Particularly in the diabetic
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that leads to the up-regulation of transforming growth factor β and to
increased collagen I production [6,40].
The enhanced Tyr705 phosphorylation of STAT3, observed in thehigh
glucose condition, increased STAT3 nuclear localization, in agreement
with the previousfindings showing that STAT3 tyrosinephosphorylation
is a key event for the STAT3 nuclear migration [9]. The raise of ROS pro-
duction observed with high glucose and Ang II stimulation was impor-
tant for nuclear STAT3 accumulation since ROS depletion greatly
decreased STAT3migration. It was intriguing to observe that Ang II addi-
tion, after 2 h of pre-incubation of CFs in high glucose, did not enhance
JAK2 and STAT3 tyrosine phosphorylation. This result was completely
different from the previous observations in cardiomyocytes. In healthy
human ventricular myocytes Ang II activates JAK2 phosphorylation
only in the presence of high glucose leading to enhancement of ROS
generation. Conversely, in failing myocytes, high glucose induces JAK2
phosphorylation via an angiotensin converting enzyme-dependent Ang
II autocrine production [7]. In addition, Ang II-induced JAK2 activation
is followed by STAT3 phosphorylation in healthy cardiac myocytes [8].
In the latter condition, Ang II contemporary activates different intracellu-
lar pathways. Ang II induces the overexpression of the associated B cell
lymphoma (Bcl)-xL through a JAK2- and extracellular signal-regulated
kinase (ERK) 1/2-dependent mechanism, while p38MAPK cascade
leads to the activation of the Fas ligand (Fas-L) [8]. Although JAK2 and
STAT3 phosphorylation is unaffected by Ang II stimulation in high glu-
cose, a significant increase of nuclear STAT3 has been detected in re-
sponse to Ang II in high glucose medium. Recent results show that
hyperglycemic condition induces CF proliferation by activating STAT1/
STAT3 and ERK1/2 signaling pathways [41]. In particular, ERK1/2 path-
way is involved in collagen types I and III production in fibroblasts ex-
posed to high glucose concentrations [42]. ERK1/2 activation due to
Ang II stimulation in fibroblasts has been reported [43,44]. Our findings
suggest that the enhanced nuclear STAT3 localization involves ERK1/2
activation. Activated ERK1/2 is involved in the rapid STAT3 serine 727
phosphorylation which modulates STAT3 transcriptional activity [45,
46]. Although further studies are needed to knowdeeply themechanism
underlying the increased nuclear STAT3 due to Ang II in the setting of
high glucose, the participation of the Ang II-ERK1/2-STAT3 pathway
can be hypothesized.
Our findings show that glucose and Ang II act in synergy (at least in
the early phase of hyperglycemic condition) leading to the increased
amount of phosphorylated STAT3 in the nucleus. Transcriptional activi-
ty of STAT3 is enhanced by p300 co-factor [47] and inhibited by protein
inhibitors of STAT3 [48]. Transcriptional regulation of COL1A2 gene, re-
sponsible for collagen I biosynthesis during development and in fibrotic
conditions, occurs through cis-acting elements and trans-acting factors
implicated in constitutive, cytokine-modulated and tissue-specific
expression of COL1A2 [49]. Currently, there are no data regarding the
presence of STAT3 elements in the collagen I promoter, thus suggesting
that STAT3 may act through an indirect mechanism. Although it is clear
that hyperglycemia leads to enhanced fibrosis, the underlying molecu-
larmechanism is not fully elucidated. The increased collagen production
due to fibroblasts exposed to high glucose is not associated with en-
hanced extracellular matrix degradation by MMPs [5]. As consequence,
there is an imbalance between synthesis and degradation of extracellu-
lar matrix which is shifted toward matrix accumulation [50]. Here, we
observe that MMP-2 secretion is unaffected by both glucose and Ang
II, thus contributing to the enhancement of extracellular matrix
deposition.
The previous findings suggest that ROS are involved in Ang II-
dependent collagen production [51] and focused on STAT3 as a respon-
sible molecule for collagen deposition in the onset of fibrosis [52]. In
conclusion, we report for the first time that the increased collagen I de-
position in high glucose occurred through a ROS- and STAT3-dependent
mechanism. Indeed, both ROS depletion and the STAT3 silencing inhibit
collagen I production due to high glucose in CFs. Ang II stimulation inthe early phase of hyperglycemia provokes an increased burst of ROS
leading to enhancement of STAT3 nuclear localization through a
mechanism involving ERK1/2.
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